Human trial
MIF-1 primary study · PMID 7989637
20 patients with major depression in a short blinded pilot study.
Reported findings. Symptom ratings improved in an exploratory trial.
Nonresponse. Nonresponse frequency not established in this excerpt.
Harms. Unknown in reviewed excerpt; absence of mention is not safety evidence.
Limits. Small historical study, limited replication and duration. No conclusion about general mood enhancement or long-term safety.
Preparation: Source preparation; commercial equivalence unverified. Route: subcutaneous
Read original source ↗Editorial review 2026-10-09. Clinician review pending.